View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry

Blog

Scientific Luminaries to Keynote at 3rd Annual PODD


  • June 14, 2013

  • Industry leaders and life science legends Dr Robert Langer and Dr George M. Whitesides keynote the Partnership Opportunities in Drug Delivery Conference presented by the Conference Forum. The event presents a strategic level program on pharma/biotech drug delivery partnership opportunities.

    New York, New York (PRWEB) June 12, 2013

    The Conference Forum is pleased to announce the keynotes for the 3rd annual PODD: Partnership Opportunities in Drug Delivery event, which takes place on October 10-11 in Boston. PODD is strategic level networking event designed to bring drug delivery innovators together with key decision makers at pharmaceutical, biotechnology and medical device companies. This event provides the opportunity to learn about cutting-edge delivery technologies and meet with senior level executives and scientists.

    To kick-off the PODD event, Robert Langer, PhD, David H. Koch Institute Professor at MIT will engage in a fireside style chat to discuss the difference between success and failure of drug delivery technologies.

    On the second day of the conference George M. Whitesides, PhD, Woodford L. and Ann A. Flowers University Professor, Harvard University and Founding Core Faculty Member, Wyss Institute will address how drug delivery will disrupt the future of healthcare.

    PODD is chaired by Barbara Lueckel, PhD, Global Business Development Director, Roche and features a wide range of drug delivery technologies, pharmaceutical and biotech business development panels, together with new discussions related to delivering biologics, role of drug delivery in the R&D pipeline, nanomedicine, and funding in the drug delivery sector.

    We are excited to bring all the major components together that advance drug delivery partnerships,” Valerie Bowling, Executive Director of the Conference Forum.

    Other conference highlights include:
    ⁃    How drug delivery is disrupting the diagnostics industry
    ⁃    Who is funding drug delivery
    ⁃    The next paradigm on how biologics will be delivered
    ⁃    New deal structures and models
    ⁃    POV from heads of R&D on the role of drug delivery
    ⁃    Partnering and networking tools and facilities

    To learn more about the PODD conference, visit http://www.theconferenceforum.org.

    About the Conference Forum

    The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.

    Related Links:
    Dr Robert S. Langer, PhD, Biography
    Dr George Whitesides, PhD, Biography
    Barbara Lueckel, PhD, Biography